ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe

Access to biomolecular technologies has become an essential requirement to ensure optimal and timely treatment of patients with cancer. This study sought to provide a comprehensive overview of the availability and accessibility of biomolecular technologies to patients, the status of their use and pr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Annals of oncology 2023-10, Vol.34 (10), p.934-945
Hauptverfasser:	Bayle, A., Bonastre, J., Chaltiel, D., Latino, N., Rouleau, E., Peters, S., Galotti, M., Bricalli, G., Besse, B., Giuliani, R.
Format:	Artikel
Sprache:	eng
Schlagworte:	access availability biomarkers biomolecular technologies Cancer cancer medicines Life Sciences NGS oncology precision medicine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!